Clinical trials
Withdrawn Carcinoid Tumor trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Medical Center | 1 |
| British Columbia Cancer Agency | 1 |
| Massachusetts General Hospital | 1 |
| Stanford University | 1 |
| University of Alabama at Birmingham | 1 |
| University of Chicago | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoid Tumor | 7 |
| Neuroendocrine Tumors | 5 |
| Insulinoma | 2 |
| Vipoma | 2 |
| Adrenal Cortex Neoplasms | 1 |
| Carcinoma, Medullary | 1 |
| Carcinoma, Merkel Cell | 1 |
| Gastrinoma | 1 |
| Glucagonoma | 1 |
| Multiple Endocrine Neoplasia Type 1 | 1 |
Trials
Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.